Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A Infection

Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary <i>Streptococcus pneumoniae</i> Challenge during Influenza A Infection

Secondary bacterial pneumonia is responsible for significant morbidity and mortality during seasonal and pandemic influenza. Due to the unpredictability of influenza A virus evolution and the time-consuming process of manufacturing strain-specific influenza vaccines, recent efforts have been focused...

Full description

Bibliographic Details
Main Authors: Sean Roberts, Clare M. Williams, Sharon L. Salmon, Jesse L. Bonin, Dennis W. Metzger, Yoichi Furuya
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Vaccines
Subjects:
influenza-pneumococcal co-infection
pneumococcal vaccination
pneumococcal surface protein a
<i>streptococcus pneumoniae</i>
prevnar
Online Access:https://www.mdpi.com/2076-393X/7/4/146

Internet

https://www.mdpi.com/2076-393X/7/4/146

Similar Items